Additionally, elevated levels of the NKG2D ligand major histocompatibility complex (MHC) class I associated chains A and B (MICA/B) in the liver have been observed in MASH patients, suggesting a potential involvement of NK cells in MASH progression through interactions with MICA/B (101). This evidence concerns the gene HLA-C and metabolic dysfunction-associated steatohepatitis.